Viral Clearance Market Share, Size, Trends, Industry Analysis Report, By Method (Viral Removal Method, Viral Inactivation Method, and Viral Detection Method); By Application; By End User; By Region; Segment Forecast, 2024 – 2032

Viral Clearance Market Share, Size, Trends, Industry Analysis Report, By Method (Viral Removal Method, Viral Inactivation Method, and Viral Detection Method); By Application; By End User; By Region; Segment Forecast, 2024 – 2032

The global viral clearance market size is expected to reach USD 1464.76 million by 2032, according to a new study by Polaris Market Research. The report “Viral Clearance Market Share, Size, Trends, Industry Analysis Report, By Method (Viral Removal Method, Viral Inactivation Method, and Viral Detection Method); By Application; By End User; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing demand for biosimilars and generics worldwide and greater need for sophisticated and cheap therapies for chronic diseases, are prominent factors driving the market’s growth. Additionally, the surging penetration for the detection of virus removal or inactivation during the early stages of development and rising preference for outsourcing of viral clearances among leading pharma and biotechnology companies, are further anticipated to boost global market growth.

• For instance, in June 2023, Texcell, announced about the opening of its newest testing facility in North America that shows company’s commitment towards advancing the viral safety of biotherapeutics and medical devices. The new facility is specially designed to support simultaneous viral clearance and biosafety studies.

There are several methods being used for testing of harmful viruses in biologics. There is an increasing proliferation for the advent of next-generation sequencing which holds great promise in accurate and fast detection of known and unknown contaminating viruses. It allows sensitive and specific testing of wide range of viral contaminants, creating a growth potential for the market. For instance, in July 2023, Integrated DNA Technologies, unveiled its new next-generation sequencing solution called “xGen Respiratory Virus Amplicon Panel”.

Furthermore, there has been an increase in the awareness about viral safety and its significance in the healthcare industry, which has been underlined by several types of viral illnesses like Human Immunodeficiency Virus, hepatitis, and Zika virus. Also, the need for gene treatments and personalized medicine that allows for the development of targeted antiviral treatments and enhanced immune response, which in turn, generating huge growth potential for the market.

Viral Clearance Market Report Highlights

• Viral removal method segment accounted for the noteworthy share, due to its beneficial properties and rising emergence of new virus threats globally
• Vaccines segment held the largest share, that is driven by increasing demand and need for various types of vaccines to boost immunization of patient
• CROs segment will grow at substantial growth rate, on account of growing prevalence for outsourcing of early-phase development and testing services
• Asia Pacific will grow fastest, due to presence of huge untapped market and rising disposable income
• North America dominated the global market, on account of region’s greater awareness about the importance of viral clearance
• The key market players include Charles River Laboratories, Merck KgaA, Syngene International Limited, WuXi Biologics, Clean Cells, and Allure Medical Group

Polaris Market Research has segmented the viral clearance market report based on method, application, end user, and region:

Viral Clearance, Method Outlook (Revenue - USD Million, 2019 - 2032)

• Viral Removal Method
• Viral Inactivation Method
• Viral Detection Method

Viral Clearance, Application Outlook (Revenue - USD Million, 2019 - 2032)

• Blood and Blood Products
• Recombinant Proteins
• Cellular & Gene
• Therapy Products
• Vaccines
• Others

Viral Clearance, End User Outlook (Revenue - USD Million, 2019 - 2032)

• Pharmaceutical and Biotech Industry
• Academic Research Institutes
• CROs
• Others

Viral Clearance, Regional Outlook (Revenue - USD Million, 2019 - 2032)

• North America

- U.S.

- Canada

• Europe

- Germany

- UK

- France

- Italy

- Spain

- Russia

- Netherlands

• Asia Pacific

- China

- India

- Japan

- South Korea

- Indonesia

- Malaysia

• Latin America

- Argentina

- Brazil

- Mexico

• Middle East & Africa

- UAE

- Saudi Arabia

- Israel

- South Africa